UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030142
Receipt No. R000034427
Scientific Title A Phase Ib study of osimertinib with ramucirumab in EGFR mutated lung adenocarcinoma patients. (LY3009806-IIT-01)
Date of disclosure of the study information 2017/11/28
Last modified on 2019/12/10 22:52:16

No. Disposal Last modified on Item of update
1 Insert 2017/11/28 05:44:18
2 Update 2017/11/28 05:45:35 Key inclusion criteria
3 Update 2018/08/12 02:22:27 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
4 Update 2019/04/24 13:18:40 Public title
Public title
Scientific Title
Scientific Title
5 Update 2019/04/24 13:20:10 Public title
Scientific Title
6 Update 2019/04/24 14:14:38 Public title
Scientific Title
7 Update 2019/12/10 22:42:15 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/12/10 22:51:48 Recruitment status
Date of IRB
Last follow-up date
9 Update 2019/12/10 22:52:16 Number of participants that the trial has enrolled


Contact us.